| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 2 | +18,100 | 2.8% | $7.62 | +$137,850 |
| Sells | 5 | -619,719 | 97% | $12.34 | -$7,647,898 |
| Net | -3 | -601,619 | -94% | -$7,510,048 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| ALS Invest 1 B.V. | 10%+ Owner | $96,258,721 | 06 Jul 2022 | ||
| Morningside Venture Investments Ltd | 10%+ Owner | $81,596,447 | 15 Aug 2023 | ||
| Joshua B. Cohen | Co-Chief Executive Officer, Director | $48,299,548 | -$3,119,354 | -6.1% | 02 Mar 2026 |
| Justin B. Klee | Co-Chief Executive Officer, Director | $48,257,562 | -$3,119,943 | -6.1% | 02 Mar 2026 |
| DRAGSA 96 LLC | 10%+ Owner | $37,554,630 | 11 Jan 2022 | ||
| VIKING GLOBAL INVESTORS LP | 10%+ Owner | $30,222,333 | 08 Sep 2022 | ||
| GEORGE M. MILNE JR | Director | $9,819,602 | 12 Jan 2026 | ||
| Margaret Olinger | Chief Commercial Officer | $5,178,792 | 27 Dec 2023 | ||
| Patrick D. Yeramian | Chief Medical Officer | $3,357,139 | 09 Jan 2024 | ||
| JAMES M. FRATES | Chief Financial Officer | $2,563,546 | -$396,358 | -13% | 02 Mar 2026 |
| Camille L. Bedrosian | Chief Medical Officer | $2,468,422 | -$407,224 | -14% | 02 Mar 2026 |
| Gina Mazzariello | Chief Legal Officer | $1,951,990 | -$605,018 | -24% | 02 Mar 2026 |
| Karen Firestone | Director | $785,595 | +$100,845 | +15% | 23 Dec 2025 |
| Bernhardt Zeiher | Director | $37,005 | +$37,005 | 05 Jun 2025 | |
| Daphne Quimi | Director | 05 Jun 2025 | |||
| Isaac Cheng | Director | 09 Jun 2022 | |||
| PAUL R. FONTEYNE | Director | 05 Jun 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|